2024-05-27 05:30:00 ET
Summary
- A monthly chart of PFE using Worden’s TC2000 Gold shows the stock oversold on a monthly basis.
- A stock with a 5.8-6% dividend yield in today’s market immediately draws attention.
- Is the dividend sustainable, and will the pharma giant be able to sustain the current $0.42 per quarter ($1.68 per year) dividend pace and also continue to boost that dividend at a $0.04 per year (one penny per quarter) rate?
A couple of weeks ago, this blog’s technician (Gary S. Morrow) shot me a message, noting that he thought Pfizer ( PFE ) was putting in a longer-term bottom....
Read the full article on Seeking Alpha
For further details see:
Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe?